Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tamer Abdelgawad"'
Autor:
Humaid O. Al-Shamsi, Nadia Abdelwahed, Aydah Al-Awadhi, Mohamed Albashir, Amin M. Abyad, Saeed Rafii, Mehdi Afrit, Bilal Al Lababidi, Ibrahim Abu-Gheida, Yoginee Pundlik Sonawane, Neil A. Nijhawan, Urfan Ul Haq, Norbert Dreier, Thanda Lucy Ann Joshua, Faryal Iqbal, Tamer Yacoub, Faisal A. Nawaz, Dima Abdul Jabbar, Syed Hammad Tirmazy, Dalia M. El-shourbagy, Dina Hamza, Mohamed Omara, Sawsan Abdul Salam Al Madhi, Hassan Ghazal, Humaa Darr, Muharrem Oner, Zoi Vlamaki, Abdul Rahman El Kinge, Dorai Ramanathan, Mohammed Judah, Taghreed Almahmeed, Mudhasir Ahmad, Sai Babu Jonnada, Nahla Almansoori, Aly A. Razek, Annett Al-Hamadi, Nahed Balalaa, Faek Jamali, Ramanujam Anugonda Singarachari, Abdelrahman Labban, Kaltar Das, Ernest J.T. Luiten, Tamer Abdelgawad, Falah Al-Khatib, Sadir Alrawi, Hassan Jaafar
Publikováno v:
JCO Global Oncology, Vol , Iss 9 (2023)
Externí odkaz:
https://doaj.org/article/1d4dfd88e83f471496fb96c307e1f39c
Autor:
Humaid, Al-Shamsi, Humaa, Darr, Ibrahim, Abu-Gheida, Jawaher, Ansari, Martine C, McManus, Hassan, Jaafar, Syed Hammad, Tirmazy, Maroun, Elkhoury, Fathi, Azribi, Danijela, Jelovac, Tarik A, Doufan, Abdel Rahman, Labban, Ahmad Ali, Basha, Ahmed, Samir, Aladdin, Maarraoui, Ali, Al Dameh, Aydah, Al-Awadhi, Basel, Al Haj Ali, Batool, Aboud, Dalia, Elshorbagy, Diaa, Trad, Dima, Abdul Jabbar, Dina, Hamza, Ed, Ashtar, Emad, Dawoud, Essa M, Aleassa, Faraz, Khan, Faryal, Iqbal, Hala, Abdellatif, Mehdi, Afrit, Mohamad H, Masri, Mohamed, Abuhaleeqa, Mohamed, Alfalasi, Mohamed, Omara, Mohanad, Diab, Muhammad Farooq, Latif, Muharram, Oner, Norbert, Dreier, Omar, Almarzouqi, R A, Singarachari, Riyad, Bendardaf, Sadir, Alrawi, Salman Sray, Aldeen, Shabeeha, Rana, Soha, Talima, Tamer, Abdelgawad, Abhinav, Ahluwalia, Thamir, Alkasab, Tamer, Madi, Tarek, Alkhouri, Urfan, Ul Haq, Yazan Z, Alabed, Mohamad, Azzam, Zulfaqqar, Ali, Maher A, Abbas, Aly Abdel, Razek, Falah, Al-Khatib
Publikováno v:
The Gulf journal of oncology. 1(32)
With cancer being the third leading cause of mortality in the United Arab Emirates (UAE), there has been significant investment from the government and private health care providers to enhance the quality of cancer care in the UAE. The UAE is a devel
Autor:
David Howard, David C. Grabowski, Gregory Smith, J. Sollano, Michael E. Chernew, Tamer Abdelgawad
Publikováno v:
Health Affairs. 35:1581-1587
Spending on anticancer drugs has risen rapidly over the past two decades. A key policy question is whether new anticancer drugs offer value, given their high cost. Using data from the Surveillance, Epidemiology, and End Results (SEER)-Medicare databa
Autor:
J.P. Doherty, G. Makinson, B. Leinwand, J. Sollano, D. Munch, Gregory Smith, F. Ali, Tamer Abdelgawad, M. Johnsrud, S. Kamal-Bahl
Publikováno v:
Value in Health. 22:S514
Autor:
Michael R. Eber, Darius N. Lakdawalla, Tamer Abdelgawad, Tomas Philipson, Dana P. Goldman, David C. Grabowski, Michael E. Chernew, Larry Z. Liu, Andreas Kuznik
Publikováno v:
Health affairs (Project Hope). 31(10)
Statins are considered a clinically important breakthrough for the treatment of cardiovascular disease. However, their social value at the US population level has not previously been studied. From an economic perspective, social value measures the qu
Autor:
Lisa Egbuonu-Davis, Tamer Abdelgawad
Publikováno v:
PharmacoEconomics. 24
Background: When Medicaid preferred drug lists (PDLs) are implemented, they may impose indirect costs on prescribing physicians and Medicaid patients, leading to an unintended reduction in the number of Medicaid prescriptions filled. Objective: To te
Autor:
Matthew M, Murawski, Tamer, Abdelgawad
Publikováno v:
The American journal of managed care.
To conduct an exploratory investigation of the possible effects of the implementation of a state Medicaid preferred drug list (PDL) on the average number of visits by Medicaid patients to hospitals and physicians, and to provide preliminary estimates
Autor:
Howard DH; David H. Howard (david.howard@emory.edu) is an associate professor in the Department of Health Policy and Management at Emory University, in Atlanta, Georgia., Chernew ME; Michael E. Chernew is a professor in the Department of Health Care Policy at Harvard Medical School, in Boston, Massachusetts., Abdelgawad T; Tamer Abdelgawad is a senior director of global health economics and outcomes resaerch at Pfizer Inc. in New York City., Smith GL; Gregory L. Smith is a senior director of global health economics and outcomes research at Pfizer Inc., Sollano J; Josephine Sollano is a senior director of global health economics and outcomes research at Pfizer Inc., Grabowski DC; David C. Grabowski is a professor in the Department of Health Care Policy at Harvard Medical School.
Publikováno v:
Health affairs (Project Hope) [Health Aff (Millwood)] 2016 Sep 01; Vol. 35 (9), pp. 1581-7.